✨ Unlock Data Exports And Disclosure Access. Start Your 30-Day Free Trial Today →

Gilead Sciences Inc

Common Name
Gilead Sciences
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
17,000
Ticker
GILD
Exchange
NASDAQ/NGS
Description
Gilead Sciences, Inc. is a biopharmaceutical company that discovers, develops, and commercializes innovative medicines addressing unmet medical needs in the United States, Europe, and other internatio...

Gilead Sciences's Financial Statements Preview

Below are the financial statements of Gilead Sciences, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Interested in getting early access to our real-time standardized financial datafeed?
Learn More
All figures in millions of USD
2024
2023
2022
Revenues
Product sales
28,610a
26,934a
26,982a
Royalty, contract and other revenues
144a
182a
299a
Total revenues
28,754a
27,116a
27,281a
Costs and expenses
Cost of goods sold
-6,251a
-6,498a
-5,657a
Research and development expenses
-5,907a
-5,718a
-4,977a
Acquired in-process research and development expenses
-4,663a
-1,155a
-944a
In-process research and development impairments
-4,180a
-50a
-2,700a
Selling, general and administrative expenses
-6,091a
-6,090a
-5,673a
Total costs and expenses
-27,092a
-19,511a
-19,951a
Operating income
1,662a
7,605a
7,330a
Interest expense
-977a
-944a
-935a
Other (income) expense, net
-6a
-198a
581a
Income before income taxes
690a
6,859a
5,814a
Income tax expense
-211a
-1,247a
-1,248a
Net income
480a
5,613a
4,566a
Net loss attributable to noncontrolling interest
0a
-52a
-26a
Net income attributable to Gilead
480a
5,665a
4,592a
Limited Data Preview
You are viewing a limited preview of Gilead Sciences’s income statement data. The reported financial values are complete. The full dataset, available for download, additionally includes structured metadata for each line item, such as line item role (line item, subtotal, total) and financial classification (e.g., assets, liabilities, equity, revenue, expenses).
Access Datasets, Disclosures, and Sources
pro
Remove manual data sourcing from your workflow. Subscribe to Tracenable Pro to get credits for accessing and exporting datasets and disclosures across 8,500+ companies with 10+ years of historical coverage.
Download granular datasets (CSV/XLS)
Access underlying corporate disclosures (PDF)
Trace all values back to their original sources
Formats Included
Excel
CSV
Json
All data fully traceable to original sources
Used by 1,000+ teams in finance, climate, and research

Verified Sources Behind Gilead Sciences’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Gilead Sciences’s data sources below and access millions more through our Disclosure Search.

a. Gilead Sciences's 10-K 2024
Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

Tracenable is building real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?